StockData
Merck & Co., Inc. logo

Merck & Co., Inc.

MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$149.52+3.19 (+2.18%)

Close on Oct 30, 2026Market cap $368.89BP/E 119.6Yield 2.19%

Merck Non-GAAP Net Income Attributable to Merck & Co., Inc. by Year

Non-GAAP Net Income Attributable to Merck & Co., Inc. ($M) ($M)

Merck Non-GAAP Net Income Attributable to Merck & Co., Inc.: $22,513M in FY2025, up 15.8% from a year earlier.

Latest, FY2025
22,513
Period ended Dec 31, 2025
Change on a year earlier
+15.8%
19,444 in FY2024
History
5 years
Since FY2020
Sources
4
Documents cited below

Where the FY2025 figure comes from

“|| Net Income Attributable to Merck & Co., Inc., Rahway, N.J., USA | 18,254 | (2,482 | ) | (2,078 | ) | 241 | 60 | (4,259 | ) | 22,513”

Source: Form 8-K (tm264564d1_ex99-1.htm, filed 2026-02-03) ↗

Reported in Form 8-K Table 2a GAAP to Non-GAAP Reconciliation.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedNon-GAAP Net Income Attributable to Merck & Co., Inc. ($M) ($M)Year on yearSource
FY2025Dec 31, 202522,513+15.8%Form 8-K (tm264564d1_ex99-1.htm, filed 2026-02-03) ↗
FY2024Dec 31, 202419,444+406.8%Form 8-K (tm264564d1_ex99-1.htm, filed 2026-02-03) ↗
FY2023Dec 31, 20233,837-79.8%Form 8-K (tm255059d1_ex99-1.htm, filed 2025-02-04) ↗
FY2022Dec 31, 202219,005–Form 8-K (tm244517d1_ex99-1.htm, filed 2024-02-01) ↗
FY2020Dec 31, 202011,506–Form 8-K (tm222755d1_ex99-1.htm, filed 2022-02-03) ↗

Cite this data

StockData. (2026). Merck Non-GAAP Net Income Attributable to Merck & Co., Inc. ($M), annual FY2020–FY2025 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/nongaap-net-inc

See every metric in the Merck KPI table. Data updated Oct 26, 2026.